1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin . 2011;61(2):69-90.
2. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin . 2014;64(1):9-29.
3. Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML. Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst. 2011;103(2): 117-128.
4. Davies L, Welch HG. Epidemiology of head and neck cancer in the United States. Otolaryngol Head Neck Surg. 2006;135(3):451-457.
5. Hashibe M, Brennan P, Chuang SC, et al. Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev . 2009;18(2):541-550.
6. Rodriguez T, Altieri A, Chatenoud L, et al. Risk factors for oral and pharyngeal cancer in young adults. Oral Oncol. 2004;40(2):207-213.
7. National Survey on Drug Use and Health. Alcohol Use and Alcohol-Related Risk Behaviors Among Veterans . NIH publication 99-4323. Rockville, MD: National Institutes of Health, U.S. Dept of Health and Human Services; 2005.
8. McKinney WP, McIntire DD, Carmody TJ, Joseph A. Comparing the smoking behavior of veterans and nonveterans. Public Health Rep . 1997;112(3):212-217.
9. Smith EA, Malone RE. “Everywhere the soldier will be”: wartime tobacco promotion in the US military. Am J Public Health . 2009;99(9):1595-1602.
10. James R, Olstad S. Cigarette advertising. Time. June 15, 2009.
11. Miller DR, Kalman D, Ren XS, Lee AF, Niu Z, Kazis LE. Health Behaviors of Veterans in the VHA: Tobacco Use: 1999 Large Health Survey of VHA Enrollees . Washington, DC: Office of Quality and Performance, Veterans Health Administration, U.S. Dept of Veterans Affairs; 2001.
12. Bray RM, Hourani LL, Rae Olmstead KL, et al. 2005 Department of Defense Survey of Health Related Behaviors Among Active Duty Military Personnel: A Component of the Defense Lifestyle Assessment Program (DLAP). Report prepared for U.S. Dept of Defense (Cooperative Agreement No. DAMD17-00-2-0057). Research Triangle Park, NC: RTI International; 2006.
13. Stevens MH, Gardner JW, Parkin JL, Johnson LP. Head and neck cancer survival and life-style change. Arch Otolaryngol . 1983;109(11):746-749.
14. Marron M, Boffetta P, Zhang ZF, et al. Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk. Int J Epidemiol . 2010;39(1):182-196.
15. Gillison ML. Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin Oncol . 2004;31(6):744-754.
16. Pathmanathan R, Prasad U, Sadler R, Flynn K, Raab-Traub N. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med . 1995;333(11):693-698.
17. Bazemore AW, Smucker DR. Lymphadenopathy and malignancy. Am Fam Physician . 2002;66(11):2103-2110.
18. American Cancer Society. Oral cavity and oropharyngeal cancer. American Cancer Society website. http://www.cancer.org/acs/groups/cid/documents/webcontent/003128-pdf.pdf. Updated January 27, 2016. Accessed July 6, 2016.
19. Pandey M, Rao LP, Das SR, Mathews A, Chacko EM, Naik BR. Patterns of mandibular invasion in oral squamous cell carcinoma of the mandibular region. World J Surg Oncol . 2007;5:12.
20. Leung SF, Zee B, Ma BB, et al. Plasma Epstein-Barr viral deoxyribonucleic acid quantitation complements tumor-node-metastasis staging prognostication in nasopharyngeal carcinoma. J Clin Oncol. 2006;24(34):5414-5418.
21. Dickson PV, Davidoff AM. Malignant neoplasms of the head and neck. Semin Pediatr Surg. 2006;15(2):92-98.
22. Lefebvre JL, Coche-Dequeant B, Van JT, Buisset E, Adenis A. Cervical lymph nodes from an unknown primary tumor in 190 patients. Am J Surg . 1990;160(4):443-446.
23. Bhattacharyya N. Predictive factors for neoplasia and malignancy in a neck mass. Arch Otolaryngol Head Neck Surg . 1999;125(3):303-307.
24. Dailey SH, Sataloff RT. Lymphoma: an update on evolving trends in staging and management. Ear Nose Throat J . 2001;80(3):164-170.
25. Schwarz R, Chan NH, MacFarlane JK. Fine needle aspiration cytology in the evaluation of head and neck masses. Am J Surg . 1990;159(5):482-485.
26. Carvalho AL, Nishimoto IN, Califano JA, Kowalski LP. Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer . 2005;114(5):806-816.
27. Jones AV, Craig GT, Speight PM, Franklin CD. The range and demographics of salivary gland tumours diagnosed in a UK population. Oral Oncol . 2008;44(4):407-417.
28. Shebl FM, Bhatia K, Engels EA. Salivary gland and nasopharyngeal cancers in individuals with acquired immunodeficiency syndrome in United States. Int J Cancer . 2010;126(10):2503-2508.
29. Bien´ E, Balcerska A. Clinical significance of erythrocyte sedimentation rate, C-reactive protein and serum lactate dehydrogenase levels in the diagnosis, prognosis and treatment monitoring of children suffering from cancer [in Polish]. Med Wieku Rozwoj. 2004;8(4, pt 2):1081-1089.
30. Wu M, Burstein DE, Yuan S, et al. A comparative study of 200 fine needle aspiration biopsies performed by clinicians and cytopathologists. Laryngoscope . 2006;116(7):1212-1215.
31. Liu ES, Bernstein JM, Sculerati N, Wu HC. Fine needle aspiration biopsy of pediatric head and neck masses. Int J Pediatr Otorhinolaryngol . 2001;60(2):135-140.
32. Story DA. Postoperative complications in elderly patients and their significance for long-term prognosis. Curr Opin Anaesthesiol . 2008;21(3):375-379.
33. Head BA, Heitz L, Keeney C, et al. The relationship between weight loss and health-related quality of life in persons treated for head and neck cancer. Support Care Cancer . 2011;19(10):1511-1518.
34. van den Berg MG, Rasmussen-Conrad EL, van Nispen L, van Binsbergen JJ,Oral Oncol. 2008;44(9):830-837.
35. Murphy BA, Deng J. Advances in supportive care for late effects of head and neck cancer. J Clin Oncol . 2015;33(29):3314-3321.
36. Pandey M, Devi N, Thomas BC, Kumar SV, Krishnan R, Ramdas K. Distress overlaps with anxiety and depression in patients with head and neck cancer. Psychooncology. 2007;16(6):582-586.
37. World Health Organization. Cancer Pain Relief: With a Guide to Opioid Availability .
38. Epstein JB, Thariat J, Bensadoun RJ, et al. Oral complications of cancer and cancerCA Cancer J Clin. 2012;62(6):400-422.
